| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 22.98% |
| RVMD | REVOLUTION MEDICINES INC | 2.82% |
| INSM | INSMED INC | 2.70% |
| EYPT | EYEPOINT INC | 2.68% |
| EWTX | EDGEWISE THERAPEUTICS | 2.59% |
| CYTK | CYTOKINETICS INC | 2.44% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.19% |
| PCVX | VAXCYTE INC | 2.17% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2.08% |
| IMVT | IMMUNOVANT INC | 1.98% |
| TARS | TARSUS PHARMACEUTICALS | 1.91% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 1.90% |
| DYN | DYNE THERAPEUTICS, INC. | 1.80% |
| AZN | ASTRAZENECA PLC | 1.73% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.72% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.69% |
| DNLI | DENALI THERAPEUTICS INC. | 1.65% |
| ARGX | ARGENX SE ADR | 1.52% |
| HCA | HCA HOLDINGS INC | 1.50% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.48% |
| PSNL | PERSONALIS | 1.48% |
| HALO | HALOZYME THERAPEUTICS INC | 1.45% |
| GKOS | GLAUKOS CORPORATION | 1.45% |
| MCK | MCKESSON CORP | 1.38% |
| THC | TENET HEALTHCARE CORP | 1.37% |
| ABBV | ABBVIE INC | 1.28% |
| REGN | REGENERON PHARMACEUTICALS | 1.23% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.19% |
| MDT | MEDTRONIC PLC | 1.19% |
| DHR | DANAHER CORP | 1.18% |
| UNH | UNITEDHEALTH GROUP INC | 1.16% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.15% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.12% |
| RGEN | REPLIGEN CORP | 1.09% |
| RMD | RESMED INC | 1.07% |
| SNY | SANOFI- AVENTIS- ADR | 1.05% |
| CDXS | CODEXIS INC | 1.04% |
| KRRO | KORRO BIO | 1.03% |
| BDX | BECTON DICKINSON & CO | 1.01% |
| ALC | ALCON INC | 1.01% |
| SYK | STRYKER CORP | 1.00% |
| TNDM | TANDEM DIABETES CARE INC | 0.97% |
| ELV | ELEVANCE HEALTH INC | 0.94% |
| HUM | HUMANA INC | 0.92% |
| VCEL | VERICEL CORP | 0.92% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.91% |
| ICLR | ICON PLC | 0.91% |
| ISRG | INTUITIVE SURGICAL INC | 0.90% |
| ABT | ABBOTT LABORATORIES | 0.88% |
| DXCM | DEXCOM INC | 0.88% |
| ZTS | ZOETIS INC | 0.82% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.75% |
| SPRY | ARS PHARMACEUTICALS | 0.70% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.70% |
| BSX | BOSTON SCIENTIFIC | 0.67% |
| ADMA | ADMA BIOLOGICS, INC. | 0.58% |
| LENZ | LENZ THERAPEUTICS | 0.41% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.39% |
| WAT | WATERS CORP | 0.28% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.